Phase Ib First in Human Dose Escalation of GT103 in Refractory, Advanced Stage Non-Small Cell Lung Cancer (TOP 1902)
Clinical trial NCT04314089 · COMPLETED
Trial details
- NCT number
- NCT04314089
- Sponsor
- Edward Patz
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-09
- Primary completion
- 2024-04-11
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.